↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$564KSold on the market
1Companies
Sep 4, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 202619:54 | Sep 4, 2026 | VCYTVERACYTE, INC. | Chief Scientific & Med Officer | S · Sell10b5-1 | $43.05 | −13,110 | 133,048 | -9% | −$564K | ||
| Sep 4, 202619:54 | Sep 2, 2026 | VCYTVERACYTE, INC. | Chief Scientific & Med Officer | F · Tax10b5-1 | $44.88 | −3,639 | 146,158 | -2% | $163K |